Nonmyeloid Malignancies
📧 Sign up to get email alerts when something new happens for Nonmyeloid Malignancies.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-08-07Clinical Trial Update: A Trial of HHPG-19K Injection and Auto-HHPG-19K Injection in Prevention of Chemotherapy-related Moderate to Severe Neutropenia of Patients With Nonmyeloid Malignancies [Phase 3]
A Phase 3 trial evaluating HHPG-19K Injection and Auto-HHPG-19K Injection to prevent chemotherapy-related neutropenia in patients with nonmy…
-
FDA approval · 2022-05-26FDA Approved: FYLNETRA — Original Application (Amneal Pharmaceuticals LLC)
FDA approves FYLNETRA (pegfilgrastim) from Amneal as an original biologics license application to help reduce the duration of neutropenia in…
-
CLINICAL_TRIALS trial_result · 2013-05-23Clinical Trial Update: AIM 3: Anemia and Iron Management With Every 3 Week Dosing in Anemic Subjects With Nonmyeloid Malignancies [Phase 3]
Phase 3 trial AIM 3 evaluated anemia management with every-3-week dosing and iron optimization in anemic subjects with nonmyeloid malignanci…
-
CLINICAL_TRIALS trial_result · 2013-04-26Clinical Trial Update: Study to Develop a Screening Tool for Functional Capacity in Anemic Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Darbepoetin Alfa [Phase 2]
Phase 2 study to develop a screening tool for functional capacity in anemic patients with nonmyeloid malignancies undergoing chemotherapy an…